NCT04783766View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics Study of CK-3773274

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

April 10, 2021

Primary Completion Date

August 5, 2021

Study Completion Date

August 5, 2021

Conditions

Obstructive Hypertrophic CardiomyopathyHealthy Adult Subjects

Interventions

DRUG

CK-3773274

CK-3773274- Tablets

DRUG

Placebo

Placebo- Tablets

Trial Locations (1)

100032

Clinical Site, Beijing

Sponsors

Lead Sponsor

Corxel Pharmaceuticals

Collaborators (1)

All Listed Sponsors

collaborator

Cytokinetics

INDUSTRY

lead

Corxel Pharmaceuticals

INDUSTRY

NCT04783766 - Safety, Tolerability and Pharmacokinetics Study of CK-3773274 | Biotech Hunter | Biotech Hunter